Sign in to tag this notice and share notes on it with your team.
Winston AI writes a plain-English brief of every opportunity — what the buyer wants, and what affects whether to bid. It's free in every Scout workspace. Sign in to see it.
Project title: NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets
Offer reference number: CM/TNS/26/5745
Period of framework agreement: Dates detailed below, with an option or options to extend (at the discretion of the Authority) up to a maximum of 24 months.
CM/TNS/26/5745 Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg
Lot 1 DNE, LNW & SOFE 1 November 2026 to 31 October 2027 (12 months)
Lot 2 DNW & MAE 1 November 2026 to 31 October 2027 (12 months)
Published By: Medicines Procurement and Supply Chain - NHS Medicines Value & Access, NHS England
| Lot | Title | Value |
|---|---|---|
| 1 | Lot 1 | — |
| Title | Supplier | Value | Awarded |
|---|---|---|---|
| NHS National Framework for Etravirine 200mg tablets, Raltegravir 400mg tablets, Ritonavir 100mg tablets | Merck Sharpe & Dohme (UK) Limited | £8,545,000 | 28 Jul 2026 |